Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease.

scientific article published on 27 December 2017

Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1002/1873-3468.12956
P8608Fatcat IDrelease_jikdpaqnzzelfhrt7u6o4kkt6a
P932PMC publication ID6942696
P698PubMed publication ID29281123

P2093author name stringCarlos T Moraes
Nadee Nissanka
P2860cites workPremature ageing in mice expressing defective mitochondrial DNA polymeraseQ24294365
Leigh syndrome associated with mitochondrial complex I deficiency due to a novel mutation in the NDUFS1 geneQ24299919
Mutation of SOD1 in ALS: a gain of a loss of functionQ24305971
Twinkle mutations associated with autosomal dominant progressive external ophthalmoplegia lead to impaired helicase function and in vivo mtDNA replication stallingQ24310134
A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystoniaQ24561975
Amyloid plaque core protein in Alzheimer disease and Down syndromeQ24568384
How mitochondria produce reactive oxygen speciesQ24643882
A new mtDNA mutation associated with Leber hereditary optic neuroretinopathyQ24678885
INTRAMITOCHONDRIAL FIBERS WITH DNA CHARACTERISTICS. I. FIXATION AND ELECTRON STAINING REACTIONSQ24683004
Ageing and Parkinson's disease: why is advancing age the biggest risk factor?Q27021628
Mitochondrial permeability transition pore is a potential drug target for neurodegenerationQ27023850
A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegansQ27322678
Aging: a theory based on free radical and radiation chemistryQ27860549
Sequence and organization of the human mitochondrial genomeQ27860659
An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathyQ28156628
The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidantsQ28248174
The biologic clock: the mitochondria?Q28249363
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathyQ28292821
Leigh syndrome: One disorder, more than 75 monogenic causesQ38617364
Mitochondrial complex III ROS regulate adipocyte differentiationQ38666697
Review: Central nervous system involvement in mitochondrial diseaseQ38861730
Leigh syndrome associated with mitochondrial complex I deficiency due to novel mutations In NDUFV1 and NDUFS2.Q39498152
Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell lineQ40714967
Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonucleaseQ40761854
Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects.Q40871888
Complex III releases superoxide to both sides of the inner mitochondrial membraneQ28509539
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1Q28510145
Mitochondrial DNA sequence variation and neurodegenerationQ28710285
Mitochondria, oxidants, and agingQ29547594
Signal transduction by reactive oxygen speciesQ29615230
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian agingQ29616056
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson diseaseQ29619113
A defect in the mitochondrial complex III, but not complex IV, triggers early ROS-dependent damage in defined brain regions.Q30416049
Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer's diseaseQ30443526
Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 geneQ31561021
Single-cell analysis of mtDNA deletion levels in sporadic amyotrophic lateral sclerosisQ33201354
Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage.Q33274385
Mitochondrial DNA damage in a mouse model of Alzheimer's disease decreases amyloid beta plaque formationQ33608218
Mitochondrial DNA deletions and depletion within paraspinal musclesQ33777189
Selective neuronal vulnerability to oxidative stress in the brainQ33868370
The sites and topology of mitochondrial superoxide productionQ33888976
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS releaseQ33913079
High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brainQ33957039
Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular musclesQ33994118
Taking a "good" look at free radicals in the aging processQ34028033
Double-strand breaks of mouse muscle mtDNA promote large deletions similar to multiple mtDNA deletions in humansQ34062921
The clinical spectrum of the m.10191T>C mutation in complex I-deficient Leigh syndrome.Q34171965
Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in miceQ34201844
Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species productionQ34212784
Alzheimer's disease: cell-specific pathology isolates the hippocampal formationQ34261572
Early deficits in synaptic mitochondria in an Alzheimer's disease mouse modelQ34276376
Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body diseaseQ34311330
Gene regulation and DNA damage in the ageing human brainQ34326236
Oxidative damage and mitochondrial decay in agingQ34326443
Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissuesQ34362048
Neuropathological features of mitochondrial disordersQ34458266
Reactive oxygen species and signal transductionQ34497624
A new mitochondrial disease associated with mitochondrial DNA heteroplasmyQ34627393
mtDNA Variation and Analysis Using Mitomap and MitomasterQ34639880
Reactive oxygen species in the regulation of synaptic plasticity and memoryQ34805998
Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene.Q40964939
Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell linesQ41244266
The role of oxidative stress in nervous system aging.Q41298557
Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damageQ42002973
Production of reactive oxygen species by mitochondria: central role of complex III.Q42163292
The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: a useful biomarker or more?Q42435317
Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosisQ42639602
Activation of the JAK-STAT pathway by reactive oxygen species.Q42823922
Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neuronsQ43076986
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.Q43241664
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutationQ43518868
Modulation of mitochondrial dysfunction-related oxidative stress in fibroblasts of patients with Leigh syndrome by inhibition of prooxidative p66Shc pathway.Q44019814
Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease.Q44603683
Mouse L cell mitochondrial DNA molecules are selected randomly for replication throughout the cell cycleQ44625940
Shift in the localization of sites of hydrogen peroxide production in brain mitochondria by mitochondrial stressQ44959842
Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA.Q45878904
Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cellsQ46792440
Amyloid-β peptide induces mitochondrial dysfunction by inhibition of preprotein maturation.Q46844863
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patientsQ47660422
Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathyQ48153107
Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosisQ48349098
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced ageQ48403808
Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosisQ48540035
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neuronsQ48588748
Mitochondrial DNA homeostasis is essential for nigrostriatal integrityQ48830759
Leigh syndrome: clinical features and biochemical and DNA abnormalities.Q49107059
Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 geneQ49291677
Early-onset familial parkinsonism due to POLG mutationsQ50278596
Population prevalence of the MELAS A3243G mutationQ50459050
Random point mutations with major effects on protein-coding genes are the driving force behind premature aging in mtDNA mutator mice.Q53379421
Mitochondrial point mutations do not limit the natural lifespan of mice.Q55043447
Electron Transfer between Cytochrome c and p66Shc Generates Reactive Oxygen Species that Trigger Mitochondrial ApoptosisQ58454329
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathiesQ59055292
Somatic Progenitor Cell Vulnerability to Mitochondrial DNA Mutagenesis Underlies Progeroid Phenotypes in Polg Mutator MiceQ59545994
Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotesQ73035349
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell deathQ73162983
Mitochondrial DNA mutations in Leigh syndrome and their phylogenetic implicationsQ73558959
Mitochondrial DNA deletion mutation levels are elevated in ALS brainsQ74175468
Correlation of functional and ultrastructural abnormalities of mitochondria in mouse heart carrying a pathogenic mutant mtDNA with a 4696-bp deletionQ77103968
Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosisQ77499725
Introduction of heteroplasmic mitochondrial DNA (mtDNA) from a patient with NARP into two human rho degrees cell lines is associated either with selection and maintenance of NARP mutant mtDNA or failure to maintain mtDNAQ78109255
A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystoniaQ79412625
DNA deletions and clonal mutations drive premature aging in mitochondrial mutator miceQ80799366
Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson diseaseQ81229335
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's diseaseQ34915213
Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damageQ35004513
Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibersQ35015881
Mitochondrial threshold effects.Q35017647
Regulation of yeast chronological life span by TORC1 via adaptive mitochondrial ROS signalingQ35032890
The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctionsQ35219902
The mtDNA mutation spectrum of the progeroid Polg mutator mouse includes abundant control region multimersQ35219919
Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiationQ35234787
Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation.Q35372063
Reactive oxygen species and the central nervous systemQ35389986
Increased mitochondrial DNA deletions in substantia nigra dopamine neurons of the aged rat.Q35547453
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's diseaseQ35660223
Epigenetics, epidemiology and mitochondrial DNA diseases.Q35832776
Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons.Q35852144
Mitochondrial metabolism of reactive oxygen species.Q36088215
The submitochondrial distribution of ubiquinone affects respiration in long-lived Mclk1+/- miceQ36317215
A compositional segmentation of the human mitochondrial genome is related to heterogeneities in the guanine mutation rate.Q36372760
Screening of effective pharmacological treatments for MELAS syndrome using yeasts, fibroblasts and cybrid models of the diseaseQ36419316
Ageing and neuronal vulnerabilityQ36428039
Mouse mtDNA mutant model of Leber hereditary optic neuropathy.Q36471358
Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial diseaseQ36532577
DNA replication and transcription in mammalian mitochondriaQ36780113
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's diseaseQ36947501
The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregatesQ37003482
Mouse models of mitochondrial DNA defects and their relevance for human diseaseQ37087221
Human mitochondrial DNA replication machinery and diseaseQ37322422
The low abundance of clonally expanded mitochondrial DNA point mutations in aged substantia nigra neuronsQ37382577
Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson diseaseQ37434427
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectivesQ37656554
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequencesQ38021865
MPTP mouse models of Parkinson's disease: an updateQ38070400
Multiple sclerosis and mitochondrial gene variations: a reviewQ38106595
The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?Q38374332
Mitochondrial DNA mutations in neurodegenerationQ38503652
DNA damage in neurodegenerative diseasesQ38563232
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectmitochondrial DNAQ27075
reactive oxygen speciesQ424361
neurodegenerationQ1755122
P1104number of pages15
P304page(s)728-742
P577publication date2018-01-09
P1433published inFEBS LettersQ1388051
P1476titleMitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
P478volume592